People In Brief
This article was originally published in The Gray Sheet
iTech Medical president
You may also be interested in...
Monteris Medical gets a new CEO. Zeltiq's chief executive resigns. More moves by movers and shakers in the medical device and diagnostics industries.
A formal Critical Path priority list to be released in the coming year will include device-focused initiatives, assured FDA Deputy Commissioner for Operations Janet Woodcock
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.